| abstract |
Progestogens, preferably dienogest, chlormadinone acetate or levornogetrel in combination with estrogens, such as ethinyl estradiol, 17βestradiol or estradiol valerate and one or more pharmaceutically acceptable excipients / carriers. There is a possibility for improving the prophylaxis of lactose intolerance in a possibly contributing factor, also in view of elaborate studies on lactose intolerance.n n n The invention is also suitable for long-term use. |